Exfoliative dermatitis - Dermatitis Ya Exfoliative
☆ AI Dermatology — Free Service
Katika matokeo ya 2022 ya Stiftung Warentest kutoka Ujerumani, kuridhika kwa watumiaji na ModelDerm kulikuwa chini kidogo kuliko na mashauriano ya matibabu ya simu yanayolipishwa.
Katika matokeo ya 2022 ya Stiftung Warentest kutoka Ujerumani, kuridhika kwa watumiaji na ModelDerm kulikuwa chini kidogo kuliko na mashauriano ya matibabu ya simu yanayolipishwa.
Red (burning) Skin Syndrome ― eritema na mabaka kwenye mwili mzima ni dalili kuu za Dermatitis Ya Exfoliative (Exfoliative dermatitis).
relevance score : -100.0%
ReferencesErythroderma ni hali ya nadra lakini mbaya ya ngozi. Ingawa sababu halisi haijulikani mara nyingi, inaweza kusababishwa na madawa (drug reaction) au saratani ya msingi. Saratani moja ya kawaida inayohusishwa na dermatitis ya exfoliative ni lymphoma ya T‑cell ya ngozi (cutaneous T‑cell lymphoma), ambayo inaweza isionyeshe dalili kwa miezi au hata miaka baada ya hali ya ngozi kuanza. Kawaida, kulazwa hospitalini inahitajika kwa uchunguzi wa awali na matibabu. Wagonjwa walio na ugonjwa unaosababishwa na dawa (drug‑induced disease) kwa ujumla wana mtazamo mzuri wa muda mrefu, ingawa kesi zisizo na sababu wazi huwa na kozi ya kurudia na ya kuporomoka. Utabiri wa kesi zinazohusishwa na saratani kawaida hutegemea jinsi saratani inavyoendelea.
Erythroderma is a rare but serious skin condition. While the exact cause is often unknown, it can be triggered by a drug reaction or an underlying cancer. One common cancer linked to exfoliative dermatitis is cutaneous T-cell lymphoma, which might not show symptoms for months or even years after the skin condition starts. Usually, hospitalization is needed for initial assessment and treatment. Patients with drug-induced disease generally have a good long-term outlook, though cases without a clear cause tend to have a recurring and remitting course. The prognosis for cases linked to cancer typically depends on how the cancer progresses.
Erythroderma is a rare but serious skin condition. While the exact cause is often unknown, it can be triggered by a drug reaction or an underlying cancer. One common cancer linked to exfoliative dermatitis is cutaneous T-cell lymphoma, which might not show symptoms for months or even years after the skin condition starts. Usually, hospitalization is needed for initial assessment and treatment. Patients with drug-induced disease generally have a good long-term outlook, though cases without a clear cause tend to have a recurring and remitting course. The prognosis for cases linked to cancer typically depends on how the cancer progresses.
Kwa kawaida huonyesha uwekundu ulioenea na kupamba hufunika zaidi ya 90% ya mwili. Hali hii ni ishara inayoonekana ya masuala mbalimbali ya kiafya kama vile psoriasis, eczema, au majibu ya dawa fulani.
It characteristically demonstrates diffuse erythema and scaling of greater than 90% of the body surface area. It is a reaction pattern and cutaneous manifestation of a myriad of underlying ailments, including psoriasis and eczema, or a reaction to the consumption of certain drugs.
It characteristically demonstrates diffuse erythema and scaling of greater than 90% of the body surface area. It is a reaction pattern and cutaneous manifestation of a myriad of underlying ailments, including psoriasis and eczema, or a reaction to the consumption of certain drugs.
Sababu ya kawaida ya erythroderma ni kuzidisha kwa ugonjwa wa ngozi, kama vile psoriasis, dermatitis ya mguso (contact dermatitis), dermatitis ya seborrheic (seborrheic dermatitis), lichen planus, pityriasis rubra pilaris au reaksheni ya dawa (drug reaction), kama vile matumizi ya steroids ya topiki (topical steroids). Uonyeshaji wa msingi ni wa nadra na kwa kawaida huonekana katika matukio ya lymphoma ya seli ya T ya ngozi. Kwa sababu ni muhimu kuitofautisha na lymphoma ya seli ya T ya ngozi, biopsi inafanywa.